Assessment of various topical oral formulations by bone marrow transplant recipients.
Topical approaches to management of oral mucositis have the advantages of high local concentration and limited or no systemic absorption, reducing the risk of systemic complications. The acceptability of topical therapies in cancer patients has not been evaluated. Thirty-eight transplant patients assessed the acceptability of three formulations (rinse, thin gel, thick gel) of a new compound developed to prevent oral mucositis. The rinse was selected as the most acceptable formulation. The thick gel received the lowest rating. Consistency was a major determinant of overall acceptability. A neutral taste was desirable for most participants. Room temperature of the formulation was rated as completely acceptable. Most participants would be willing to use the rinse or thin gel several times per day, to retain each dose in the oral cavity for up to 5 min, and to swallow it. The support of caregivers may be needed to achieve compliance with such regimens.
Bellm
L A
LA
IntraBiotics Pharmaceuticals Inc., Mountain View, CA 94043, USA.
Epstein
J B
JB
Rose-Ped
A M
AM
Fu
R
R
Martin
P J
PJ
Fuchs
H J
HJ
D000284:Administration, Oral; D000287:Administration, Topical; D000328:Adult; D016026:Bone Marrow Transplantation; D002626:Chemistry, Pharmaceutical; D005260:Female; D005782:Gels; D006801:Humans; D007407:Interviews as Topic; D008297:Male; D008875:Middle Aged; D009061:Mouth Mucosa; D009067:Mouthwashes; D009369:Neoplasms / Q000628:therapy*; D010349:Patient Compliance; D017060:Patient Satisfaction; D013280:Stomatitis / Q000209:etiology / Q000517:prevention & control*; D019172:Transplantation Conditioning / Q000009:adverse effects*
D005782:Gels; D009067:Mouthwashes